Amulet Capital Partners recently announced the closing of a recapitalization of US Fertility through a new continuation vehicle.

US Fertility, founded in 2020 and based in Rockville, Maryland, is a fertility services platform.

Amulet, founded in 2015 and based in Greenwich, Connecticut, is a middle market private equity investment firm focused exclusively on the healthcare sector. The firm typically invests between $75 million and $150 million in companies within segments that include life sciences outsourcing, payors and payor services, and providers and outsourced services.

StepStone Group, a global private markets investment firm, acted as the sole lead investor, supported by other existing and new investors. L Catterton, which joined Amulet as a co-lead investor in US Fertility in 2025, remains invested.

Terms of the transaction were not disclosed.

1315 Capital has acquired the Life Sciences and Diagnostics (LSDx) division of Argonaut Manufacturing Services, according to a news release.

The LSDx business will operate independently as Aluris Sciences. Aluris is a contract manufacturing partner providing manufacturing solutions for life sciences, diagnostics and combination drug product customers. 

1315 Capital, founded in 2014 and based in Philadelphia, is a healthcare-focused growth equity firm that invests in commercial-stage companies across healthcare services, pharma/medtech products, pharma/medtech outsourcing, and health and wellness. The firm makes equity investments of $15 million to $50 million in businesses with the potential to scale to $50 million to $200 million of revenue.

Terms of the transaction were not disclosed.

Eir Partners has acquired Accumulus Technologies, according to a news release.

Accumulus, founded in 2025 as a spinout of Accumulus Synergy and based in San Francisco, is a software-as-a-service company whose cloud platform enables life sciences organizations and global regulatory authorities to exchange data and collaborate on submissions.

Eir, founded in 2015 and based in Miami, is a middle market private equity firm focused on healthcare technology and tech-enabled services. Eir’s targeted stages of investment include growth equity through control buyouts and investment sizes ranging from $40 million to $150 million.

Terms of the transaction were not disclosed.

H.I.G. Capital recently announced that one of its affiliates had completed the acquisition of Outcomes One.

Outcomes, founded in 1977 and based in Orlando, Florida, is a provider of clinical network services and pharmacy technology.

H.I.G., founded in 1993 and based in Miami, pursues a wide range of investments in healthcare and many other industries. The firm has flexibility on investment size, including interest in pre-EBITDA businesses. Within healthcare, the firm targets companies in the provider services, hospital/major facilities and life sciences/pharmaceutical industries.

Terms of the transaction were not disclosed.

Thurston Group has acquired Pixel Health, according to a news release and a company announcement.

Pixel Health, founded in 2001 and based in Holyoke, Massachusetts, provides IT consulting and managed IT services to hospitals and large physician groups.

Thurston, founded in 1986 and based in Chicago, is a private equity firm focused on healthcare investments. The firm generally pursues companies with $1 million to $10 million in EBITDA.

Terms of the transaction were not disclosed.

BPOC recently announced strategic investments in Master Medical Equipment (MME) and ReNew Biomedical.

MME, founded in 2011 and based in Jackson, Tennessee, is a provider of EMS capital equipment, rentals and service.

ReNew, founded in 2014 and based in Jackson, Tennessee, services, repairs and maintains defibrillators, ventilators, infusion pumps, AEDs, ECGs and vital signs monitors.

MME and ReNew are sister companies.

BPOC, founded in 1996 and based in Chicago, seeks control and minority equity investments in lower middle market companies exclusively within the healthcare industry. The firm pursues companies generating at least $10 million in revenue through a wide range of investments. Within healthcare, the firm targets companies in the provider services, life sciences/pharmaceutical and non-reimbursement industries.

Terms of the investments were not disclosed.

Flexpoint Ford recently announced it sold ArtesRx to Linden Capital Partners.

ArtesRx, established in 2023 by Flexpoint and Dom Meffe, is a behavioral health pharmacy platform serving individuals who depend on complex medication regimens.

Flexpoint, founded in 2005 and based in Chicago, invests in the healthcare business and financial solutions and other sectors. The firm pursues investments from $50 million to $500 million in a single transaction, including investments in minority and majority structures in both private and public companies.

Linden, founded in 2004 and based in Chicago, is a private equity firm focused exclusively on the healthcare industry. The firm pursues acquisition opportunities across the healthcare industry, including services, products and distribution companies, and prefers to make more substantial investments from a dollars perspective.

Terms of the transaction were not disclosed.

SaaS is dead in the age of AI, say many in healthcare software.

Not so fast, says Noah Lewis, managing partner at Ardan Equity, a sector specialist at the intersection of healthcare, life sciences and technology. Arguing that the “SaaSpocalypse” is overblown, he joins McGuireWoods partner and host Geoff Cockrell to discuss AI’s impact on health tech. Noah explains how he screens for “melting ice cube risk” and sees commercialization, not technology cost, as the real competitive moat.

He also unpacks why healthcare’s aging $400 billion tech stack makes the present a golden age for health tech, and contends the market is shifting from inflationary to deflationary business models. It leads to one question: Who wins and loses as AI transforms healthcare?